Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
NCT ID: NCT00293878
Last Updated: 2007-02-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
150 participants
INTERVENTIONAL
2005-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia
NCT00404001
Effect of CP-778,875 on HDL-C in Subjects With Abnormal Lipid Levels and Type 2 Diabetes.
NCT00326326
Safety Study of BMS-770767 in Subjects With Hypercholesterolemia
NCT01058083
A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia
NCT01651273
Dyslipidemia Study Investigating The Increase In "Good Cholesterol"
NCT00169559
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Disodium Ascorbyl Phytostanol Phosphate (FM-VP4)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give informed consent and to comply with study procedures (including diet)
Exclusion Criteria
* Age \<18 or \>75 years
* Pregnant women or women of child-bearing potential
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Forbes Medi-Tech
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Warner, MD
Role: STUDY_DIRECTOR
Clinical Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coastal Clinical Research
Mobile, Alabama, United States
Radiant Research
San Diego, California, United States
Radiant Research
Daytona Beach, Florida, United States
Radiant Research
Gainesville, Florida, United States
Radiant Research
Boise, Idaho, United States
Radiant Research
Chicago, Illinois, United States
Midwest Institute for Clinical Research
Indianapolis, Indiana, United States
PRA International Pharmacology Center
Lenexa, Kansas, United States
The Center for Pharmaceutical Research
Kansas City, Missouri, United States
Radiant Research
Portland, Oregon, United States
Coastal Carolina Research Center
Mt. Pleasant, South Carolina, United States
Radiant Research
Austin, Texas, United States
Research Across America
Dallas, Texas, United States
Radiant Research
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CL2005-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.